10-Q: Church & Dwight Reports Q2 Profit Decline Amid Strategic Exits and Tariff Headwinds

Church & Dwight Co., Inc. reported a significant drop in second-quarter net income and diluted EPS, driven by strategic business exits and ongoing challenges from tariffs and higher manufacturing costs, despite a new acquisition and increased dividend.

Summary

• Net sales for the second quarter of 2025 decreased by 0.3% to $1,506.3 million, and by 1.4% to $2,973.4 million for the first six months of 2025, compared to the same periods in 2024.
• Gross profit for the second quarter of 2025 fell by 9.1% to $647.0 million, with gross margin decreasing by 410 basis points to 43.0%. For the six months, gross profit decreased by 6.6% to $1,306.6 million, and gross margin by 250 basis points to 43.9%.
• Income from operations for the second quarter of 2025 declined by 22.3% to $261.7 million, and by 13.2% to $557.0 million for the six months.
• Net income for the second quarter of 2025 was $191.0 million, a 21.6% decrease, resulting in diluted EPS of $0.78, down 21.2%. For the six months, net income was $411.1 million, down 12.8%, with diluted EPS of $1.66, down 13.1%.
• The company is exiting the Flawless, Spinbrush, and Waterpik showerhead businesses by early 2026, which generated approximately $170.0 million in annual net sales in 2024. A pre-tax charge of $51.0 million was recorded in the second quarter of 2025 due to these exits.
• A strategic review of the vitamin business (VITAFUSION and L'IL CRITTERS) is underway, expected to conclude by the end of 2025. This business experienced a full impairment of its $281.3 million trade name and a $75.8 million impairment on long-lived assets in the third quarter of 2024.
• The acquisition of Touchland Holding Corp for $700.0 million was completed on July 16, 2025, with potential additional earnout consideration up to $180.0 million.
• A new $2,000.0 million unsecured revolving credit facility was entered into on July 17, 2025, replacing the prior $1,500.0 million facility.
• The quarterly dividend was increased by 4% to $0.295 per share, equivalent to an annual dividend of $1.18 per share, declared on January 29, 2025.
• An Accelerated Share Repurchase (ASR) contract was entered into in May 2025, with $300.0 million paid and an initial delivery of 2.8 million shares.

Sentiment

Score: 4

Explanation: The company reported significant declines in key financial metrics (net sales, gross profit, operating income, net income, EPS) for both the quarter and six-month periods, primarily due to strategic business exits and ongoing cost pressures from tariffs and manufacturing. While strategic acquisitions and shareholder returns (dividends, share repurchases) are positive, the core operational performance is weak, and the outlook highlights continued challenges with inflation and consumer spending. The strategic review of the vitamin business adds further uncertainty.

Positives

• Increased quarterly cash dividend by 4% to $0.295 per share, demonstrating commitment to shareholder returns.
• Entered into a new $2,000.0 million unsecured revolving credit facility, enhancing liquidity and financial flexibility.
• Completed the acquisition of Touchland Holding Corp for $700.0 million, adding a growth brand to the portfolio.
• Net cash used in investing activities decreased to $39.6 million for the six months ended June 30, 2025, from $91.5 million in the prior year.
• Productivity programs contributed positively to gross margin, offsetting some manufacturing cost increases.
• Consumer International segment net sales increased by 5.3% in Q2 2025 and 4.0% for the six months, driven by strong performance in HERO acne treatment products and THERABREATH mouthwash.

Negatives

• Net sales decreased by 0.3% in Q2 2025 and 1.4% for the six months ended June 30, 2025, compared to the prior year periods.
• Gross profit declined by 9.1% in Q2 2025 and 6.6% for the six months, primarily due to costs associated with exiting product lines and the absence of prior-year tariff refunds.
• Gross margin decreased by 410 basis points in Q2 2025 and 250 basis points for the six months.
• Income from operations decreased significantly by 22.3% in Q2 2025 and 13.2% for the six months.
• Net income and diluted EPS saw substantial declines of over 21% in Q2 2025 and over 12% for the six months.
• Recorded a pre-tax charge of $51.0 million in Q2 2025 related to exiting the Flawless, Spinbrush, and Waterpik showerhead businesses.
• The VMS business (VITAFUSION and L'IL CRITTERS) experienced a full impairment of its $281.3 million trade name and a $75.8 million impairment on long-lived assets in Q3 2024 due to declining market share and profitability.
• The WATERPIK business is experiencing declining sales and profits due to lower consumer spending, increased competition from value brands, and tariffs on products imported from China.
• Net cash provided by operating activities decreased by $83.4 million for the six months ended June 30, 2025, primarily due to increased working capital and decreased cash earnings.
• Higher manufacturing costs (including labor, commodities, and tariffs) negatively impacted gross margin.

Risks

• Increased supply chain challenges, commodity cost volatility, and consumer and economic uncertainty due to rapid changes in U.S. trade policies, including recent sweeping tariff increases and retaliatory tariffs by foreign countries.
• Projected twelve-month run-rate gross tariff costs of approximately $60.0 million, which could impact profitability.
• U.S. consumers are increasingly worried about persistent inflation and looming tariffs, leading to reduced discretionary spending.
• Retailers are lowering consumer-packaged goods inventories and making targeted decisions to build inventory of certain products in advance of additional tariffs, potentially impacting sales.
• The VMS business faces significant product competition from new category entrants, including private label, leading to market share decline and deterioration in financial performance.
• The global WATERPIK business has experienced a significant decline in customer demand due to lower consumer spending for discretionary products from inflation and a growing number of water flosser consumers switching to more value-branded products.
• Waterpik's profitability is impacted by tariffs imposed on its products imported into the United States that were manufactured in China.
• The WATERPIK trade name, with a carrying value of $644.7 million as of October 1, 2024, may be susceptible to future impairment if its fair value continues to decline.
• The impact of the "One Big Beautiful Bill Act" (OBBBA) on the company's financial position, results of operations, and cash flows is still being evaluated.
• General risks associated with global economic conditions, natural disasters, public health crises, political crises, and financial market conditions.
• Risks related to the successful integration of the Touchland Acquisition and the realization of expected cost savings.
• Risks that the announced strategic alternatives for certain businesses may not be completed or realize intended benefits, and that the announcement itself could have an adverse effect.

Future Outlook

The company anticipates that cash from operations, combined with current borrowing capacity, will be sufficient to fund share repurchase programs, debt and interest payments, dividends at the latest approved rate, and capital expenditure program costs of approximately $130.0 million in 2025, including investments in manufacturing capacity for THERABREATH and Sterimar, and an enterprise resource planning (ERP) project. Cash and borrowing capacity may also be utilized for future acquisitions. The company is evaluating the impact of the "One Big Beautiful Bill Act" (OBBBA) on its financial position, results of operations, and cash flows. A strategic review of the vitamin business is expected to conclude by the end of 2025.

Management Comments

• "We continue to experience increased supply chain challenges, commodity cost volatility, and consumer and economic uncertainty primarily due to rapid changes in U.S. trade policies including recent sweeping tariff increases, as well as retaliatory tariffs by foreign countries."
• "U.S. consumers are increasingly worried about persistent inflation and looming tariffs, leading them to cut back on discretionary spending."
• "We believe that retailers are lowering their consumer-packaged goods inventories and making targeted decisions to build inventory of certain products in advance of additional tariffs."
• "While the tariff situation remains fluid, we are focused on managing through these challenges."
• "From a gross risk perspective, we are currently projecting twelve-month run-rate gross tariff costs of approximately $60.0 million."
• "Over the next 12 months, we believe our tariff cost exposure can be reduced through additional supply chain efforts and surgical pricing."
• "We do not anticipate that current economic conditions will adversely affect our ability to comply with the financial covenant in the Credit Agreement because we currently are, and anticipate that we will continue to be, in compliance with the maximum leverage ratio requirement under the Credit Agreement."

Industry Context

The consumer packaged goods (CPG) industry is facing significant headwinds from persistent inflation, which is eroding consumer purchasing power and leading to reduced discretionary spending. This is evident in the company's declining sales volumes in its Consumer Domestic segment and the struggles of its WATERPIK business. The industry is also grappling with supply chain challenges, commodity cost volatility, and the impact of evolving trade policies, particularly U.S. tariffs and retaliatory measures, which are increasing manufacturing and import costs. Retailers are responding by adjusting inventory levels, reflecting a cautious outlook on consumer demand. The company's strategic exits of underperforming brands like Flawless, Spinbrush, and Waterpik showerheads, and the review of its vitamin business, align with a broader industry trend of portfolio optimization in a challenging economic environment. The acquisition of Touchland, a hand sanitizer brand, indicates a focus on categories with perceived growth potential, possibly driven by health and hygiene trends.

Comparison to Industry Standards

• The decline in gross margin by 410 basis points in Q2 2025 and 250 basis points for the six months, partly due to higher manufacturing costs and tariffs, suggests the company is facing cost pressures that may be more pronounced or less effectively mitigated compared to some peers, or it reflects specific strategic decisions (like product line exits) that impact its unique cost structure.
• The VMS business's decline due to "significant product competition coming from new category entrants, including private label" indicates that the company's performance in this segment is below industry growth or market share retention standards, particularly against agile, lower-cost competitors.
• The WATERPIK business's struggles due to "lower consumer spending for discretionary products from inflation and a growing number of water flosser consumers switching to more value-branded products" suggests that the company's premium offerings in this category are underperforming relative to market shifts towards value, a common trend in inflationary environments across CPG.
• The company's proactive portfolio management, including divesting underperforming brands and acquiring growth brands like Touchland, is a common strategy employed by large CPG companies to optimize their portfolios in response to changing consumer preferences and market dynamics.

Legal Proceedings

• The company is subject to various pending or threatened legal, regulatory, or governmental actions in the ordinary course of business, including those related to intellectual property, commercial transactions, product liability, purported consumer class actions, employment matters, antitrust, environmental, health, safety, and other compliance-related matters.
• Such proceedings are subject to considerable uncertainty, and their outcomes and any related damages may not be reasonably predictable or estimable.
• Any such proceedings could result in a material adverse outcome negatively impacting the company's business, financial condition, results of operations, or cash flows.

Related Party Transactions

• The company held a 50% ownership interest in Armand Products Company (Armand) and ArmaKleen Company (ArmaKleen).
• In October 2024, the company sold its 50% interest in ArmaKleen to its joint venture partner.
• Purchases by the company from Armand totaled $6.2 million for the six months ended June 30, 2025 (vs. $6.7 million in 2024).
• Sales by the company to ArmaKleen were $0.0 million for the six months ended June 30, 2025 (vs. $0.6 million in 2024).
• Administration & Management Oversight Services billed by the company to Armand totaled $1.2 million for the six months ended June 30, 2025 (vs. $1.2 million in 2024).
• Outstanding Accounts Receivable from Armand were $1.8 million as of June 30, 2025 (vs. $0.7 million as of June 30, 2024).
• Outstanding Accounts Payable to Armand were $1.0 million as of June 30, 2025 (vs. $1.1 million as of June 30, 2024).

Stakeholder Impact

• Shareholders: Experienced a significant decline in diluted EPS, but also benefited from a 4% increase in the quarterly dividend and ongoing share repurchase programs. The strategic review of the vitamin business and potential impairment of the WATERPIK trade name introduce uncertainty regarding future asset values and profitability.
• Customers: May experience price increases due to the company's efforts to mitigate tariff costs. Consumer demand is impacted by inflation, leading to reduced discretionary spending and a shift towards value-branded products.
• Employees: Continue to participate in stock-based compensation plans and the discounted Employee Stock Purchase Plan (ESPP). The exit of certain product lines (Flawless, Spinbrush, Waterpik showerheads) could imply workforce adjustments, though not explicitly stated.
• Suppliers: The Supply Chain Finance program allows qualifying suppliers to elect for early payment, potentially offering more favorable terms.
• Creditors: The company maintains compliance with its maximum leverage ratio requirement under the Credit Agreement and has secured a new, larger revolving credit facility, indicating stable access to credit.

Next Steps

• Complete the exit of the Flawless, Spinbrush, and Waterpik showerhead businesses by early 2026.
• Conclude the strategic review of the vitamin business (VITAFUSION and L'IL CRITTERS) by the end of 2025.
• Determine the remaining shares to be delivered under the Accelerated Share Repurchase (ASR) contract by August 2025.
• Evaluate the impact of the "One Big Beautiful Bill Act" (OBBBA) on financial position, results of operations, and cash flows.
• Monitor the achievement of certain 2025 net sales thresholds for the Touchland Acquisition, which could trigger an earnout payment of up to $180.0 million in Q2 2026.
• Continue to manage supply chain challenges, commodity cost volatility, and mitigate tariff impacts through supply chain efforts and surgical pricing.
• Fund capital expenditure program costs of approximately $130.0 million in 2025, including manufacturing capacity investments for THERABREATH and Sterimar and an enterprise resource planning (ERP) project.

Key Dates

Recommendation

The filing presents a mixed financial picture. While the company is actively managing its portfolio through strategic divestitures of underperforming brands and a significant acquisition (Touchland) to drive future growth, the current financial performance shows notable declines in net sales, gross profit, operating income, and net income for the quarter and six-month periods. These declines are attributed to the costs of exiting businesses, higher manufacturing expenses, and the persistent impact of tariffs and inflation on consumer spending. The ongoing strategic review of the vitamin business and the susceptibility of the WATERPIK trade name to further impairment add elements of uncertainty. The increase in dividends and continued share repurchases are positive signals for shareholder returns. Given the combination of proactive strategic adjustments and significant near-term financial headwinds, a "Hold" recommendation is appropriate, suggesting investors monitor the successful execution of these strategies and the broader economic environment's impact on the company's core business.

Keywords

Consumer Goods, Household Products, Personal Care, SEC Filing, Quarterly Report, Financial Results, Profit Decline, Strategic Review, Acquisition, Tariffs, Supply Chain, Inflation, Share Repurchase, Dividend Increase, Brand Management, Consumer Domestic, Consumer International, Specialty Products